Evidence map›Paper›PMID 28904867›Full record

ArticleFEBS open bio2017

The asparagine 533 residue in the outer pore loop region of the mouse PKD2L1 channel is essential for its voltage-dependent inactivation.

Takahiro Shimizu, Taiga Higuchi, Toshihiro Toba, Chie Ohno, Takuto Fujii, Bernd Nilius, Hideki Sakai

Open access · goldAbstract read
In one paragraph

Article in FEBS open bio, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Polycystin Channel Complexes.Annual review of physiology · 2023
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Takahiro ShimizuDepartment of Pharmaceutical Physiology Graduate School of Medicine and Pharmaceutical Sciences University of Toyama Japan.
Taiga HiguchiDepartment of Pharmaceutical Physiology Graduate School of Medicine and Pharmaceutical Sciences University of Toyama Japan.
Toshihiro TobaDepartment of Pharmaceutical Physiology Graduate School of Medicine and Pharmaceutical Sciences University of Toyama Japan.
Chie OhnoDepartment of Pharmaceutical Physiology Graduate School of Medicine and Pharmaceutical Sciences University of Toyama Japan.
Takuto FujiiDepartment of Pharmaceutical Physiology Graduate School of Medicine and Pharmaceutical Sciences University of Toyama Japan.
Bernd NiliusLaboratory of Ion Channel Research Department of Cellular and Molecular Medicine KU Leuven Belgium.
Hideki SakaiDepartment of Pharmaceutical Physiology Graduate School of Medicine and Pharmaceutical Sciences University of Toyama Japan.
Tohoku Medical and Pharmaceutical University · JPUniversity of Toyama · JPKU Leuven · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Voltage-dependent inactivation of ion channels contributes to the regulation of the membrane potential of excitable cells. Mouse polycystic kidney disease 2-like 1 (PKD2L1) forms voltage-dependent nonselective cation channels, which are activated but subsequently inactivated in response to membrane depolarization. Here, we found that the mutation of an asparagine 533 residue (N533Q) in the outer pore loop region of PKD2L1 caused a marked increase in outward currents induced by depolarization. In addition, the tail current analysis demonstrated that the N533Q mutants are activated during depolarization but the subsequent inactivation does not occur. Interestingly, the N533Q mutants lacked the channel activation triggered by the removal of stimuli such as extracellular alkalization and heating. Our findings suggest that the N533 residue in the outer pore loop region of PKD2L1 has a key role in the voltage-dependent channel inactivation.

Indexed as

channelinactivationPKD2L1transient receptor potentialTRPP3

Identifiers

PMID28904867
PMCPMC5586397
OpenAlexW2741632983

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.